Pharyngeal collapse in obstructive sleep apnea patients is likely a product of a sleep-related decrement in pharyngeal dilator muscle activity superimposed upon abnormal airway anatomy. We postulate that during wakefulness, increased pharyngeal dilator muscle activity in apnea patients compensates for diminished airway size thus maintaining patency. We studied the waking genioglossus (GG) electromyogram (EMG) activity in 11 OSA patients and 14 age-matched controls to determine if GG activity is higher in the awake state in apnea patients than controls. To make this determination, we developed a reproducible methodology whereby true maximal GG EMG could be defined and thus basal activity quantitated as a percentage of this maximal value. Therefore, direct comparisons of basal activity between individuals was possible. We observed apnea patients to have significantly greater basal genioglossal activity compared to controls (40.6±5.6% vs. 12.
Introduction
The precise explanation for pharyngeal collapse during sleep in patients with obstructive sleep apnea (OSA)l remains unclear. Most investigators (1) (2) (3) (4) would argue it to be a product of a sleep-induced fall in upper airway dilator muscle activity occurring in an individual with an anatomically small pharyngeal airway. Although the preponderance of data supports the concept that sleep apnea patients do have reduced pharyngeal airway size (5) (6) (7) , this is frequently difficult to document (8, 9) inasmuch as these patients have little apparent difficulty maintaining adequate airway patency during wakefulness. In addition, the data addressing the influence of sleep on pharyngeal dilator muscle activity in apnea patients and normal subjects are inconsistent and potentially confusing.
The genioglossus (GG) is the pharyngeal dilator muscle that has been most extensively studied in both apnea patients and normal subjects. This is due to its important anatomical location and function in influencing upper airway patency as well as its ease ofinstrumentation. At this time, there appears to be a dichotomy between OSA patients and normal subjects regarding the influence of non-rapid eye movement (NREM) sleep on GG activity. A number of investigators (1, 2) have demonstrated the genioglossal EMG to fall during NREM sleep in OSA patients. Conversely, current literature (10, I 1) indicates that the activity of the genioglossus is well maintained in normal individuals while asleep. No adequate explanation for this discrepancy is currently available.
A variety of studies (12) (13) (14) (15) (16) (17) (18) (19) in animals and humans indicates that the pharyngeal muscles (including the GG) can respond to changes in the local upper airway milieu. The most potent local stimulus to pharyngeal muscle activity appears to be negative intraluminal airway pressure (12) (13) (14) (15) (16) (17) (18) (19) , with several authors demonstrating in both animals (12, 13, 15, 16) and humans (17, 19) a reflex genioglossal response to negative airway pressure. In an individual with reduced pharyngeal airway size (such as an apnea patient), greater intraluminal negative pressure is generated during inspiration. Theoretically, this increased negative airway pressure could reflexly stimulate upper airway muscle activity, thus dilating the pharyngeal airway and maintaining reasonable levels of airflow resistance during wakefulness.
If such mechanisms are active in humans, apnea patients would be expected to have greater pharyngeal dilator muscle activity present during wakefulness than is encountered in normal subjects. Such neuromuscular compensation would not only maintain airway patency while awake but could potentially make it difficult to discern differences in waking airway luminal size in apnea patients versus controls using standard imaging techniques. With the onset ofsleep, these neuromuscular mechanisms in the human upper airway may be lost leading to a decline in muscle activity and pharyngeal collapse in the apnea patient. In normal subjects in whom such compensatory mechanisms are not required to maintain airway patency, little change in muscle activity would be expected during NREM sleep. Thus, this hypothesis would explain both the discrepancy in sleep effect on pharyngeal dilator muscle activity in apnea patients versus normal individuals as well as why apnea patients can maintain airway patency during wakefulness yet fail to do so asleep. There are considerable data which support the concept that respiratory compensatory mechanisms are lost during sleep. The ability to compensate for inspiratory-resistive loads is diminished during NREM sleep (20, 21) , the cough reflex is lost while asleep (22, 23) , and the ventilatory responses to chemical stimuli (hypoxia and hypercapnia) are markedly reduced during sleep (24-28). Therefore, it would not be surprising that a local neuromuscular compensatory mechanism active in the pharyngeal airway during wakefulness might also be inhibited during sleep.
To document the validity of this series of hypotheses, it must be demonstrated that (a) apnea patients have greater pharyngeal muscle (genioglossus) activity present during wakefulness than normal controls, (b) the augmented muscle activity in apnea patients can be inhibited if the appropriate stimulus (probably negative intrapharyngeal pressure) is eliminated (yielding levels of muscle activity similar to normals), (c) sleep produces a loss of this neuromuscular compensation in apnea patients again yielding levels of muscle activity similar to controls, and (d) the sleep-related loss of augmented muscle activity in apnea patients correlates temporally with airway collapse. Most of the concepts described above require methodology whereby the electromyogram (EMG), as a measure of muscle activity, can be directly compared between one individual and another. However, such direct comparison between individuals has not been possible before this time. In this paper we (a) describe a reproducible method of comparing GG muscle activity between subjects, (b) demonstrate that during wakefulness OSA patients have significantly increased GG EMG activity when compared to normal subjects, and (c) demonstrate that positive airway pressure inhibits the genioglossal EMG in apnea patients yielding levels similar to those observed in normal controls.
Methods
We initially studied 11 males with OSA and 11 healthy age-matched controls with no historical evidence ofbreathing disorders during sleep (Table I ). All apnea patients had > 25 apneas plus hypopneas per hour of sleep but no history of cardiac or pulmonary disease. Each was newly diagnosed with predominantely obstructive events (defined below) and thus was receiving no therapy for the sleep apnea at the time of our evaluation. Our original intent had been to match patients and controls only for age. However, to exclude any influence of obesity (a common trait in apnea patients) on our observations, three size-matched obese controls documented to be free of apnea by polysomnography (< 10 apneas plus hypopneas per hour of sleep) were subsequently studied.
When these individuals were added to our control group, we were able to age and size (body mass index) match five patients to five controls (Table II) . Thus, when comparing apnea patients to controls, two comparisons will be made: all patients (n = 11) versus all controls (n = 14) and age plus size-matched controls (n = 5) versus patients (n = 5). The protocol had the prior approval of the institution's Clinical Investigation Committee with each subject or patient giving informed consent. Figure 1 . Maneuvers to define maximum GG EMG. Representative raw data from one apnea patient and one normal control demonstrating the maneuvers used to determine maximal genioglossal EMG in all subjects and patients. Each individual has his own scale of EMG activity (from electrical 0 to 100%). In addition, this figure demonstrates that basal EMG was a much greater percentage of maximum in the apnea patient than the control.
Techniques
Supraglottic resistance. The Millar catheter was inserted through an anesthetized (4% lidocaine), decongested (oxymetazoline HCl1) nostril and located at the level of the epiglottis by direct visualization through the mouth. Mask pressure and flow were determine as described above. Supraglottic resistance was calculated as (epiglottic pressure minus mask pressure)/flow and was determined at both peak inspiratory flow and a inspiratory flow rate of 0.2 liters/s. Genioglossal EMG. Genioglossal EMG was measured by using a pair of unipolar intramuscular electrodes referenced to a single ground thus producing a bipolar recording. Two 25-gauge needles containing 30-gauge, teflon-coated, stainless steel wires were inserted perorally 2 cm into the body of the GG muscle at points-3 mm lateral to the frenulum and midway between the first mandibular incisor and the sublingual fold (3). The needles were quickly removed leaving the wires in place. The EMG signals were amplified, rectified, and integrated by a resistance-capacitance circuit on a moving time average basis with a time constant of 100 ms (CWE, Inc., Ardmore, PA). Both the raw and moving time average signals were recorded.
To compare the genioglossal EMG between subjects and patients the following methodology was developed. As the actual electrical signal cannot be directly compared between individuals, we attempted to define the true maximal genioglossal EMG using a variety ofreproducible, quantifiable maximal respiratory and nonrespiratory maneuvers. Once maximum (100%) was defined, the moving time average EMG signal could be scaled between 0 (electrical 0) and 100% (the highest EMG signal encountered during any of the maneuvers described). Thus, basal activity could be measured on this scale and compared between individuals. Maximum genioglossal EMG was produced using a variety of maneuvers which we observed to consistently maximally stimulate this muscle. These maneuvers included: (a) swallow, (b) 30 s of maximum voluntary hyperventilation under isocapnia conditions (Pco2 held constant by the addition of CO2 to the inspiratory line), (c) maximal inspiratory effort against an occluded airway, and (d) maximal forceful protrusion of the tongue against the maxillary alveolar ridge or the lingual force transducer (Fig. 1) . The maximal EMG defined by means of these maneuvers is quite different from the "maximal genioglossal EMG" previously described by numerous investigators (32) (33) (34) . In such studies, the authors defined maximal EMG as the highest EMG value encountered during chemostimulation (usually in response to hypercapnia) and used this value as a reference point in scaling the EMG. We observed that neither hypoxia nor hypercapnia produced a level of muscle activity that even approached that encountered with the volitional maneuvers described above. Because we desired a true maximal signal, these maneuvers were chosen and we believe the maximum EMG was defined.
In most individuals, all maneuvers produced a similar level of GG EMG activity. However, for each subject, the highest EMG signal encountered (defined as 100%b) was always achieved during either the maximal inspiratory effort against an occluded airway or maximal tongue protrusion. 92% of the time the tongue protrusion maneuver yielded the highest EMG signal. The mean difference between these two maneuvers (tongue protrusion versus effort against an occluded airway) was 15.4±3.0%. During these two maneuvers (maximum inspiratory effort against an occluded airway and tongue protrusion) we also measured the effort generated by each individual to insure similar maximal effort between groups. During all occluded inspiratory efforts, we measured the negative inspiratory pressure generated in the mask. During tongue protrusion in four apnea patients and four controls we measured tongue force against the lingual force transducer. The tongue protrusion against the transducer was a similar functional maneuver to the tongue protrusion against the maxillary alveolar ridge and in all eight subjects studied the two maneuvers produced virtually identical levels of GG EMG activity. We found no difference between apnea patients and controls in lingual force (Table III) , but there was a small but significant difference in the maximum inspiratory pressure generated with controls generating higher negative inspiratory pressure.
Protocol
Subjects and patients were studied in a semirecumbent (450) Supraglottic resistance was determined before placement of EMG electrodes using the techniques and equipment described above. This resistance was calculated over 20 breaths with mean values being reported. The Millar catheter was then removed, followed by insertion of the genioglossal recording electrodes. Once these electrodes were in place, maximum GG EMG was determined (as described) and the moving time average signal scaled from electrical 0 to 100% (maximum signal). GG EMG was then recorded during basal unstimulated (nasal) breathing for at least 5 min and expressed as a percentage ofmaximum. Finally, the nasal CPAP mask was placed and the GG EMG recorded while 5 and subsequently 10 cm H20 CPAP was applied to the mask. Data were recorded for at least 5 min during each level of CPAP. All equipment was then removed after which the subjects and patients were free to leave.
To assess the reproducibility ofour technique, we quantitated genioglossal activity a second time in three apnea patients and three controls several days to several months after their initial study.
Data analysis EMG quantitation. The GG EMG signal was scaled as described above and then recorded during quiet, nasal respiration for 5 min. Each breath on every other 30-s epoch (a total of 2.5 min of recorded data) was subsequently analyzed thus defining the basal EMG. GG moving time average EMG was quantitated as peak phasic and tonic activity in each individual and expressed as a percentage oftheir own maximum.
During CPAP administration, all signals again were recorded for 5 min at both 5 and 10 cm H20 pressure. Once again, we analyzed every other 30-s epoch over the 5-min period yielding 2.5 min of meaned data for each CPAP level. GG EMG was again quantitated as peak phasic and tonic activity and expressed as a percentage of the individual's maximal signal.
Airflow resistance. Supraglottic resistance (from above the epiglottis to the external nares) was determined as described above (see subsection Techniques). The resistance was determined at both peak inspiratory flow and at an inspiratory airflow of 0.2 liters/s over 20 consecutive breaths using Millar plus mask pressures and inspiratory flow.
To statistically assess between group (patients versus controls) differences in age, body mass index, GG EMG, airflow resistance, lingual force, and negative inspiratory pressure, unpaired t testing was used. As stated previously, this statistical approach was applied to two samples: all patients versus all controls and age-plus size-matched patients versus controls. To determine the effect ofCPAP in each group a parametric two-way analysis of variance and Student-Newman-Keuls multiple comparison test were employed. Correlations between airway resistance and genioglossal activity in apnea patients were made using linear regression analysis. Statistical significance was accepted when P < 0.05.
To assess the reproducibility of our genioglossal measurement we determined the intraclass correlation coefficient on the six subjects (three apnea patients and three controls) who underwent testing on two Cumulative data from all subjects and patients demonstrating that apnea patients have a higher mean supraglottic resistance compared to normal controls. *P < 0.05 vs. controls.
occasions. The intraclass correlation coefficient is a ratio of the between sample variability to the sum ofthe between sample and within sample variability. The interclass correlation coefficient to ranges from 0 to 1 with 1 being perfect agreement and > 0.75 considered very good to excellent agreement (35) .
Results
Adequate signals were obtained in all participants with phasic inspiratory genioglossal activity being encountered in all subjects and patients. However, in two control and two apnea patients, technical problems prevented measurement of supraglottic resistance. In one ofthese same apnea patients, artifact precluded our ability to measure GG EMG during nasal CPAP administration. Representative raw data from one apnea patient and one normal control demonstrating both the basal EMG and the maneuvers used to determine maximal genioglossal EMG are shown in Fig. 1 . Supraglottic resistance. As can be seen in Fig. 2 , mean supraglottic resistance at both peak flow and at 0.2 liter/s flow was greater in the apnea patients (10.8±1.5 and 10.2±1.7 cm H20 per liter/s) compared to controls (4.3±0.6 and 4.0±0.5 cm H20 per liter/s) although there was considerable overlap between groups.
GG EMG activity during quiet nasal breathing. As can be seen in Fig. 3 , the basal peak phasic GG activity of apnea patients represents a significantly higher percentage of maximum activity when compared to controls (40.6±5.6% vs. 12.7±1.7% of maximum) although there was some overlap between groups. Fig. 4 demonstrates that both peak phasic and tonic genioglossal activity are significantly different between these two groups with apnea patients demonstrating substantially greater relative muscle activity.
A linear regression analysis was performed assessing the relationship between supraglottic resistance and basal peak phasic GG EMG activity (percentage of maximum) in all participants (patients and controls). A significant correlation was found (r = 0.48, P = 0.03) between these variables indicating greater muscle activity in individuals with higher resistance (Fig. 5 ).
GG EMG activity in age-and size-matched individuals. The GG EMG was compared between apnea patients and con- (N=11) Figure 3 . Peak phasic GG EMG activity. Cumulative data from all subjects and patients demonstrating that in the basal state, the genioglossus functions at a higher percentage of maximum in OSA patients than controls. *P < 0.05 vs. controls. (Table II) . As demonstrated in Fig. 6 , there is again a highly significant difference in basal GG EMG activity expressed as a percentage of maximum in these two groups (apnea patients 40.2±6.7 vs. controls 7.8±0.7). GG EMG activity during nasal CPAP administration. With CPAP administration (Fig. 7) , peak phasic GG EMG activity fell significantly in apnea patients but demonstrated little change in the control subjects. In apnea patients, with 5 cm H20 CPAP the EMG fell 46 .4% to a level of 21 .6% of maximum and with 10 cm H20, the EMG fell 48.2% to a level of 20 .1% of maximum. In the controls, with 5 cm H20 CPAP the EMG only fell 2. 1% to a level of 12.0% ofmaximum while with 10 cm H20 there was virtually no change (0.4% fall) from the basal state. However, as shown, peak phasic activity remained significantly higher in apnea patients than controls even during CPAP administration.
Reproducibility. As can be seen in Fig. 8 some intrasubject variability does exist in our genioglossal activity measurement. However, the mean GG activity value for all subjects studied during trials 1 and 2 was not different (25.1±7.0 vs. 21.1±8.3). In addition, the intraclass correlation coefficient is 0.77 indicating very good to excellent agreement for our measurements (35) . We believe this supports the reproducibility and validity of our technique.
Discussion
The principal observations in this study are (a) that GG EMG activity is higher during wakefulness in apnea patients than age-and size-matched controls assumedly in response to diminished airway patency, (b) that despite this increased muscle activity, supraglottic resistance remains higher in the apnea patients, and (c) that CPAP, which delivers positive pressure to the airway, markedly inhibits genioglossal EMG activity in apnea patients but has little effect in control subjects. This decrement in muscle activity in apnea patients likely represents inhibition of a neuromuscular reflex designed to preserve airway patency. Furthermore, in this report we describe a reproducible new technique for quantifying GG muscle activity which allows comparisons between individuals. (N=5) Figure 4 . Peak phasic and tonic GG EMG activity. Mean data from all subjects and patients demonstrating that both peak phasic and tonic genioglossal EMG activity was higher in apnea patients compared to controls. *P < 0.05 vs. controls. Figure 6 . Peak phasic GG EMG activity: age and size-matched data. Cumulative data from five OSA patients and five controls matched for age and body mass index demonstrating that genioglossal activity is higher in apnea patients than controls. *P < 0.05 vs. controls. Employing this technique on our two subject populations, we found apnea patients to have a significantly and substantially higher percentage of maximal muscle activity (both peak phasic and tonic) present in the basal state than normal controls (Fig. 3) . We believe this increased muscle activity to be a neuromuscular compensatory response to abnormal airway anatomy in an attempt to maintain adequate airway patency. As addressed previously, the preponderance of data indicate that apnea patients have both reduced pharyngeal airway size (5-7) and potentially a more compliant or collapsible airway (45, 46) . This agrees with our observation of a higher mean supraglottic resistance (Fig. 2) in apnea patients than controls as has been reported previously (9, 46, 47) . This increased resistance occurs despite the augmented GG muscle activity demonstrated in these patients because such a neuromuscular compensatory mechanism is unlikely to be complete and thus not fully restore the airway to normal dimensions or resistance (Fig. 2) . On the other hand, this augmented muscle activity may help explain why some authors (9) have been unable to demonstrate clear differences in airway luminal size between apnea patients and age/weight-matched controls when the airway was imaged veen individ-during wakefulness. These results also agree conceptually with ssessment of the studies of Suratt et al. (43) . Using surface electrodes, they the influence determined the percentage of time that the GG muscle had a nuli on mus-phasic signal in apnea patients versus controls. They observed and positive apnea patients to have more phasic activity during both wake-3, 10, 11, 32-fulness and nonobstructed sleep. Because of technical limita-,d important tions, they could not directly compare muscle activity between Lctivity, these groups. However, Suratt et al. (43) did speculate that the GG ;eline muscle muscle was probably more active in apnea patients in an ate have develtempt to compensate for threatened airway patency.
im GO EMG
As shown in Fig. 3 , two ofthe apnea patients demonstrated )nrespiratory lower levels of GG muscle activity which clearly overlapped ro and maxn-with our normal subjects. We doubt this represented a techni- In apnea patients, greater intraluminal negative pressure is generated during inspiration to overcome increased airway resistance. Thus, the augmented genioglossus muscle activity that we have demonstrated may be a reflex response to increased intraluminal negative pressure. This speculation is strengthened by our CPAP results. CPAP, as described by Kuna and Remmers (53) , renders upper airway pressure positive rather than negative and, in addition, as suggested by Strohl and Redline (54) , may pneumatically splint the pharyngeal airway. Thus, we would expect that reversing intraluminal airway pressure from negative to positive and preventing airway collapse would turn off reflex stimulation of the genioglossus and obviate the need for increased GG muscle activity. As apnea patients have, during normal breathing, greater airway negative pressure as well as a more "collapsible" airway (45, 46) , CPAP would be expected to have a greater impact upon apnea patients than controls. This is clearly the case as is shown in Figure 7 . These results are consistent with the findings of both Strohl and Redline (54) and Kuna et al. (39) who observed marked reductions in upper airway muscle activity in response to nasal CPAP (GG and alae nasi) in OSA patients. However, negative intraluminal pressure is unlikely to explain the augmented tonic GG muscle activity encountered in apnea patients (Fig. 4) as airway pressure is positive during this respiratory phase. In addition, CPAP pressures up to 10 cm H20 did not completely return even peak phasic GG EMG to the levels encountered in the controls (Fig. 7) . Therefore, we would have to speculate that additional sources ofmuscle stimulation must exist in the pharyngeal airway of apnea patients which may relate to arterial chemistry or pharyngeal receptors sensitive to nonpressure stimuli.
This observed neuromuscular compensation in the GG muscle of apnea patients during wakefulness may help explain the observation of others (1, (Fig. 8) . However, we doubt this represents an important problem as there is no reason to believe that greater electrical noise exists in apnea patients compared to controls. In addition, when CPAP was applied the EMG fell substantially in the apnea patients, again suggesting that noise was not the cause of the increased muscle activity observed in these patients. Third, we could not guarantee that recording wire placement was precisely the same in all participants. Differences in wire position may explain some of the variability seen in an individual subject from one study to the next although we believe our reproducibility was quite acceptable. Fourth, differences in negative inspiratory pressure between apnea patients and controls were observed (Table III) . There is the possibility that the apnea patients were not giving similar levels of effort and therefore the maximum GG EMG was falsely low (making basal activity a falsely high percentage). However, as noted in the techniques section, maximum inspiratory effort against an occluded airway produced the sole maximum GG EMG in only 8% of all subjects (one apnea patient and one control). On the other hand, apnea patients tended to produce similar to greater force against the lingual transducer when compared to controls. In that as maximal EMG was generally defined by this tongue protrusion maneuver, it seems unlikely that varying effort influenced our results. Fifth, we did not perform clinical sleep studies on all of our control subjects including two of the age-and size-matched controls. As a result, it is possible that some of these individuals actually had the OSA syndrome. However, it has been demonstrated (55) that historical screening in low risk subjects is very effective in ruling out OSA. Also, many of the normal subjects involved in this study had participated in other research projects in our lab that actually involved some sleep monitoring. None of the subjects so studied demonstrated any sleep-disordered breathing.
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Therefore, we doubt that any of our controls had any substantial disordered breathing during sleep. Finally, although our control subjects were age-matched to the patients, most were not matched for body mass index. This represented a prospective decision not to attempt matching for weight or body mass index because we wished to compare apnea patients to truly normal age-matched controls and not obese normal subjects. However, for the subset of subjects that were weight-matched to apnea patients, our comparisons remain valid. Thus, it appears that factors other than weight are important in determining GG muscle activity.
In conclusion, we have developed new methodology for quantitatively assessing GG muscle activity. Using this technique we have observed a marked increase in GG activity in the basal unstimulated state in apnea patients compared to age-matched controls. We have also demonstrated a significant decrement in this augmented muscle activity with the application ofpositive airway pressure. We believe that this decrement in muscle activity is due to the inhibition of a neuromuscular reflex designed to preserve airway patency. We further speculate that sleep may also inhibit this reflex and therefore allow airway collapse in apnea patients. However, further investigation is needed to clearly define the effect of sleep upon this augmented GG muscle activity in apnea patients.
